New drug aims to slow rare brain disease PSP
Disease control
Ongoing
This study tests an oral drug called FNP-223 to see if it can slow the worsening of progressive supranuclear palsy (PSP), a rare brain disease that affects movement, balance, and eye control. About 241 adults aged 50 to 80 with a specific type of PSP will take the drug or a place…
Phase: PHASE2 • Sponsor: Ferrer Internacional S.A. • Aim: Disease control
Last updated May 26, 2026 12:04 UTC